⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
INmune Bio to Present at the H.C. Wainwright Global Investment Conference
globenewswire.com
INMB
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
globenewswire.com
INMB
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
globenewswire.com
INMB
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
globenewswire.com
INMB
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
globenewswire.com
INMB
INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform
globenewswire.com
INMB
INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
globenewswire.com
INMB
INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
globenewswire.com
INMB